Aptar PharmaProduct InfoAptar Pharma Launches First Metal-Free Highly Recyclable Nasal Spray PumpAptar Pharma announces the launch of APF Futurity, its first metal-free, multidose nasal spray pump ...
Aptar PharmaCompany NewsAptar Pharma Announces Collaboration with TFF PharmaceuticalsAptar Pharma announces collaboration with TFF Pharmaceuticals to develop intranasal delivery of dry ...
Aptar PharmaProduct InfoFirst Nasally-Administered Pharmaceutical Treatment for Dry Eye Disease Approved by US FDA with Aptar’s Nasal Pump SystemAptar Pharma’s patented Cartridge Pump System (CPS), was recently reviewed by the U.S. FDA as the dr...
Aptar PharmaCompany NewsAptar Pharma co-organizer and diamond sponsor of RDD Europe 2019 conference in Estoril, PortugalAptar Pharma, the leader in respiratory drug delivery systems, is proud to announce its co- organiza...
Aptar PharmaCompany NewsAptar Seeks FDA Emergency Use Authorization for Decontaminating N95 Masks with ActivShieldAptarGroup, Inc. is seeking U.S. FDA Emergency Use Authorization (EUA) for a solution that allows ea...
Aptar PharmaProduct InfoAptar Pharma’s Nasal Unidose Device approved by US FDA for new nasal seizure rescue treatmentAptar Pharma has announced that its patented Unidose Liquid System is the device delivering a new na...
Aptar PharmaProduct InfoAptar Pharma QuickStart Injectables wins Industry Innovation Award at Pharmapack 2019Aptar Pharma, a leading provider of innovative drug delivery systems, has announced that their recen...
Aptar PharmaBrand LaunchNew FDA approved combination product with Aptar Pharma's VP3 nasal spray systemAptar Pharma, a global leader in drug delivery systems, services and active material science solutio...
Aptar PharmaBrand LaunchAptar Pharma’s preservative-free multidose dispenser approved in the US for Allergan’s REFRESH RELIEVA PF artificial tear formulationAptar Pharma has announced that its innovative, preservative-free multidose Ophthalmic Squeeze Dispe...
Aptar PharmaCompany News Aptar Pharma's Preservative-Free Multidose Dispenser approved for anti-allergy treatment by French regulatory agency ANSMAptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser is the approved ...
Aptar PharmaProduct InfoAptar Pharma's nasal unidose device approved for Tosymra sumatriptan sprayAptar Pharma, a leading provider of drug delivery devices worldwide and part of AptarGroup, Inc. has...
Aptar PharmaProduct InfoAptar’s Nasal Unidose Device approved by US FDAAptarGroup, Inc, a global leader in dispensing and drug delivery solutions, has announced that its U...
Aptar PharmaCompany NewsPulmonary and nasal drug delivery experts to attend RDD Europe 2017Register now to attend the RDD Europe 2017 Scientific Conference to be held April 25-28, 2017, in A...
Aptar PharmaCompany NewsPulmonary and Nasal Drug Delivery Experts to attend RDD Europe 2017The Respiratory Drug Delivery (RDD®) Europe 2017 scientific conference will welcome pulmonary and na...
Aptar PharmaCompany NewsAptar Pharma's bidose nasal drug delivery device approved by US FDA for breakthrough treatment of depressionAptar Pharma, a leading drug delivery systems provider, has announced that its Bidose nasal spray de...
Aptar PharmaProduct InfoAptar Pharma launches eDose counter for MDIs integrating a proprietary sensing technologyAptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray deliv...
Aptar PharmaProduct InfoAptar Pharma provides unit-dose nasal spray technology for treatment of opioid overdoseAptar Pharma has announced that it has provided the delivery system and regulatory support for Adap...
.jpg)
